ABOUT THIS EVENT

I-MAB (Nasdaq: IMAB), a dynamic and rapidly growing global biotech company focused on developing novel, differentiated biologics in the areas of immuno-oncology and autoimmune diseases, visited the Nasdaq MarketSite in Times Square to ring the closing bell on their first day of trading on Nasdaq.

In honor of the occasion, Jingwu Zang, MD, PhD, Founder & Honorary Chairman, and members of the I-MAB team, rang the Closing Bell.